CNAM
GILD icon

Campbell Newman Asset Management’s Gilead Sciences GILD Stock Holding History

Campbell Newman Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-10,072
Closed -$949K – 86
2014
Q4 		$949K Sell
10,072
-10
-0.1% -$1.03K 0.18% 54
2014
Q3 		$1.07M Sell
10,082
-1,118
-10% -$109K 0.21% 48
2014
Q2 		$929K Sell
11,200
-360
-3% -$28K 0.18% 52
2014
Q1 		$819K Buy
11,560
+585
+5% +$45.9K 0.18% 60
2013
Q4 		$824K Sell
10,975
-35
-0.3% -$2.44K 0.2% 63
2013
Q3 		$692K Buy
+11,010
New +$658K 0.17% 66

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Campbell Newman Asset Management's GILD Position: Q1 2015 in Review

Campbell Newman Asset Management sold out of Gilead Sciences (GILD) in Q1 2015, closing a stake of 10,072 shares — an estimated $949K sold.

Campbell Newman Asset Management first reported a position in GILD in Q3 2013 and held it in 6 quarters. The position peaked at $1.07M in Q3 2014. 1,493 funds tracked by Wall St. Rank hold GILD as of Q1 2015.

  • Campbell Newman Asset Management reported no remaining Gilead Sciences position as of Q1 2015 after selling out during the quarter.
  • Campbell Newman Asset Management sold 10,072 Gilead Sciences shares in Q1 2015, an estimated $949K.
  • Campbell Newman Asset Management first reported a position in Gilead Sciences in Q3 2013 and held it in 6 quarters.
  • Campbell Newman Asset Management's Gilead Sciences position peaked at $1.07M in Q3 2014.
  • 1,493 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2015.

Based on Campbell Newman Asset Management's 13F filing for Q1 2015, filed 21 Apr 2015.